Inventor · disambiguated record
Carole Guillonneau
Also filed as: GUILLONNEAU CAROLE
11 granted patents·9 pending applications·4 citations·filing 2015–2024
81Inventor score
Files withINST NAT SANTE RECH MED16ABOLERIS PHARMA1CENTRE NAT RECH SCIENT1INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE1INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
20 records- 0180US11090362B2Pharmaceutical composition comprising IL-34 and a mTOR inhibitorINST NAT SANTE RECH MED·Filed 2018·Granted Aug 17, 2021·2 cites·4 claims
- 0273US12083163B2Isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseasesINST NAT SANTE RECH MED·Filed 2021·Granted Sep 10, 2024·0 cites·11 claims
- 0371US2025122300A1Anti-human cd45rc antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0463US12146159B2Methods for obtaining regulatory t cells and uses thereofINST NAT SANTE RECH MED·Filed 2020·Granted Nov 19, 2024·0 cites·12 claims
- 0561US10137181B2Isolated donor MHC-derived peptide and uses thereofINST NAT SANTE RECH MED·Filed 2015·Granted Nov 27, 2018·1 cites·10 claims
- 0661US10105425B2Isolated donor MHC-derived peptide and uses thereofINST NAT SANTE RECH MED·Filed 2015·Granted Oct 23, 2018·1 cites·12 claims
- 0759US2025281535A1Anti-human cd45rc binding domains and uses thereofABOLERIS PHARMA·Filed 2022·Application pending·0 cites
- 0856US12168694B2Anti-human CD45RC antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2019·Granted Dec 17, 2024·0 cites·20 claims
- 0956US10724001B2Methods for obtaining regulatory T cells and uses thereofINST NAT SANTE RECH MED·Filed 2016·Granted Jul 28, 2020·0 cites·12 claims
- 1052US2023147657A1Chimeric antigen receptor specific for human cd45rc and uses thereofINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1150US12054743B2Method for obtaining T cells from pluripotent stem cells, and uses thereofCENTRE NAT RECH SCIENT·Filed 2019·Granted Aug 6, 2024·0 cites·14 claims
- 1249US12466866B2Mutated interleukin-34 (IL-34) polypeptides and uses thereof in therapyINST NAT SANTE RECH MED·Filed 2020·Granted Nov 11, 2025·0 cites·12 claims
- 1348US2022064260A1Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8+cd45rclow tregsINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1447US10155025B2Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34INST NAT SANTE RECH MED·Filed 2015·Granted Dec 18, 2018·0 cites·7 claims
- 1546US10591465B2Methods and kits for labeling, detection and isolation of Foxp3+ regulatory T cells, isolated population of Foxp3+ regulatory T cells thus obtained and uses thereofINST NAT SANTE RECH MED·Filed 2016·Granted Mar 17, 2020·0 cites·17 claims
- 1645US2021147801A1Methods for increasing expansion and immunosuppressive capacity of a population of cd8+cd45rclow/- tregsINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 1744US2021163593A1Treatment of monogenic diseases with an anti-cd45rc antibodyINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 1838US2020319164A1Methods for detecting, assessing severity and treating multiple sclerosisINST NAT SANTE RECH MED·Filed 2017·Application pending·0 cites
- 1932US2018251731A1Subpopulation of cd8+cd45rclow tregs and uses thereofINSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2016·Application pending·0 cites
- 2030US2017226209A1An anti-cd45rc antibody for use as drugINSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE)·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carole Guillonneau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →